Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Long-Term Investments (2022 - 2025)

Historic Long-Term Investments for Q32 Bio (QTTB) over the last 4 years, with Q1 2025 value amounting to $2.5 million.

  • Q32 Bio's Long-Term Investments fell 4652.84% to $2.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.5 million, marking a year-over-year decrease of 4652.84%. This contributed to the annual value of $2.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Q32 Bio's Long-Term Investments is $2.5 million, which was down 4652.84% from $2.6 million recorded in Q4 2024.
  • Q32 Bio's 5-year Long-Term Investments high stood at $30.6 million for Q1 2022, and its period low was $2.5 million during Q1 2025.
  • For the 4-year period, Q32 Bio's Long-Term Investments averaged around $15.2 million, with its median value being $15.7 million (2023).
  • Per our database at Business Quant, Q32 Bio's Long-Term Investments tumbled by 2481.48% in 2023 and then crashed by 8142.86% in 2024.
  • Q32 Bio's Long-Term Investments (Quarter) stood at $25.8 million in 2022, then tumbled by 45.77% to $14.0 million in 2023, then crashed by 81.43% to $2.6 million in 2024, then decreased by 2.85% to $2.5 million in 2025.
  • Its Long-Term Investments stands at $2.5 million for Q1 2025, versus $2.6 million for Q4 2024 and $2.6 million for Q3 2024.